An interventional study of NeuroResource Facilitation (NRF) in Brain Injury, sponsored by Icahn School of Medicine at Mount Sinai. Active, not recruiting at 2 sites in United States. Open to male participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-02-23.
Sponsored by Icahn School of Medicine at Mount Sinai · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 312 studies in Brain Injuries with a site in United States — 57 open to participants now, 69 under way, none of them phase 3. Brain Injuries · United States.
Among the 312 studies in Brain Injuries with a site in United States, this one is the 4th largest by enrollment of the 223 interventional ones that give a count, is one of 11 that started in 2022, is one of 152 with no phase, reaches primary completion later than 19 of the 68 other live ones, and was the 240th registered.
947 studies on the registry are indexed under Brain Injuries; 234 are open to participants now.
Browse Brain Injuries studies →57 of the 312 studies in Brain Injuries with a site in United States are open now. Recruiting first, the newest first:
Icahn School of Medicine at Mount Sinai · Sites in United States
Ages 18+
Bridget LaMonica Ostrem, M.D., Ph.D. · Sites in United States
Ages 3 wk–20 wk
Children's Mercy Hospital Kansas City · Sites in United States
Ages up to 17
Peter C. Gerszten, MD · Sites in United States
Ages 21–75 · Healthy volunteers
Pravat Mandal · Sites in United States
Ages 30–70
A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →
Of the 152 Brain Injuries studies recruiting now, 77 (51%) set no upper age limit and 53 (35%) stop at 75 or younger; 38 take children under 18; 23 take healthy volunteers.
This study: 18 Years and older · male · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
312 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 22 · Phase 2 35 · Phase 3 9 · Phase 4 16
First in 1987; this study’s year is marked. 11 started in 2022.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 1,022 is above the median of 41 across 613 interventional studies indexed under Brain Injuries.
Median enrollment 42 across the 223 interventional studies, 85 across the 84 observational. Of the 207 that completed or were terminated, 67 (32%) have results posted.
This tab as a report to print or save as PDF → With an account.
23 of 312 have an industry lead sponsor. The 10 most frequent:
Icahn School of Medicine at Mount Sinai is the lead sponsor of 776 studies on the registry; 175 are open to participants now.
Of its 125 completed or terminated interventional studies of FDA-regulated products, 83 (66%) have results posted.
Icahn School of Medicine at Mount Sinai has 9 studies filed under Brain Injuries — fewer than ten, so there is no comparison to draw.
20 of the studies in Brain Injuries with a site in United States that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07485361University of California, Los AngelesfNIRS for Disorders of Consciousness | 2026-12 |
| NCT06725108University of ChicagoHemodynamic ABI Monitor | 2026-12-06 |
| NCT05708092Icahn School of Medicine at Mount SinaiNRF for Improved Re-Entry Outcomes for Offenders With Brain Injury (Brain Injury RE) | 2026-12-31 |
| NCT06899971Boston Children's HospitalThe Association Between Tau & GFAP and Postoperative Neurological Impairment in Patients Undergoing Cardiac Surgery | 2026-12-31 |
| NCT06855186Henry M. Jackson Foundation for the Advancement of Military MedicineSymptom-Targeted Approach to Rehabilitation for Concussion (STAR-C) | 2026-12-31 |
Add all 20 to your calendar (.ics) → With an account.
Among the 312 studies in Brain Injuries with a site in United States, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The purpose of this study is to evaluate the effectiveness of NeuroResource Facilitation, a novel/innovative intervention, in reducing recidivism in offenders with brain injury (BI).
The prevalence of brain injury (BI) is significantly greater in justice-involved populations, and a substantial proportion of prisoners have likely experienced a BI during their lifetime. A history of BI has a statistically significant association with increased use of correctional, medical and psychological services including crisis intervention; an increased frequency of institutional misconducts; and higher recidivism rates. Brain injury in justice-involved populations is frequently undiagnosed, and therefore untreated, which contributes to the cycle of recidivism. Identifying BI opens up new resources to ex- offenders that can more effectively help them to become productive in their lives in the community. In partnership with the Icahn School of Medicine at Mount Sinai, the Brain Injury Association of Pennsylvania, and the Pennsylvania Department of Corrections (PADOC), this project will implement a randomized clinical trial to determine if a case management intervention called Neurorehabilitation Facilitation (NRF) is effective in reducing recidivism by ten percent in offenders with acquired BI. Offenders in two Pennsylvania prisons (State Correctional Institution (SCI) sites in PA, SCI Phoenix, SCI Chester, SCI Frackville, and SCI Mahanoy) will be screened for BI and cognitive impairment, and those who screen positive will be randomized to receive the intervention or to receive standard of care (SoC). Two thirds of those randomized will receive the intervention and the remaining one third will serve as controls. All participants will be followed for up to three years following their release to examine the immediate and long-term reduction in recidivism.
The primary hypothesis is that NRF, as compared to SoC, will result in a 10% reduction in average 1-year recidivism, estimated by the 2013
Department of Corrections (DOC) report as 35-38%. Understanding that additional factors will contribute to the effect of NRF, the required sample was based on the primary analysis, a logistic regression of the binary response variable recidivism, adjusted for additional independent variables (described below) in the model with estimated R-squared=0.10. An effect size of 10% reduction corresponds to an odds ratio in this model of 0.643. With two thirds (67%) of cases randomized to NRF, and one third (33%) randomized to SoC, a total sample of N=688 provides 80% power at alpha set at 0.05. Anticipating that there will be a loss of approximately 10% of randomized cases to attrition, N=764 cases will be randomized, with n=509 cases randomized to NRF and 255 randomized to SoC.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
As part of the NRF intervention group, participants will receive specialized care management, both in prison and after the participant goes home. While in the State Correctional Institution (SCI), participants will meet weekly to monthly depending on resource needs, and how close participant is to release with a NeuroResource Facilitator in person who will help participants to understand more about their challenges. Participants may also be referred to a group run by the Facilitator in conjunction with staff from the prison. The facilitator will also tell the participant about resources that are available to help after the participant's release and help participants get connected to them.
Behavioral: NeuroResource Facilitation (NRF)
As part of the SoC, participants will receive the re-entry services normally receive if not in the study including (but not limited to) Treatment Services, Educational and Vocational Training, Mental Health Management, Reentry and Transitional Services, Population Management and Community Corrections.
NRF is defined as a specialized service that promotes access to services and coordinates care specific to the needs of individuals with brain injury. Possible resources include vocational services, medical assistance, Social Security (SSI or SSDI if appropriate), and other organizations that can support reentry. If needed to gain access to services and organizations, the facilitator will also provide participants with a summary that includes results from brain injury screenings questionnaire, neurocognitive (thinking abilities) tests, and symptoms. The researchers will share information and coordinate with prison and parole staff about participation in the study. Participant's information will also be shared with resources that could help participants after release, such as funding sources and brain injury services. After release from SCI, the NRF facilitator will assist the participant with all the preparation and logistics associated with the resources the participant applied to.
Number of Recidivism
According to the PADOC, rearrest is measured as the first instance of arrest after inmates are released from state prison and reincarceration is measured as the first instance of returning to state prison after an offender is released from state prison. Overall recidivism is measured as the first instance of any type of rearrest or reincarceration after inmates are released from state prison.
Time frame: at year 1
Number of Recidivism
According to the PADOC, rearrest is measured as the first instance of arrest after inmates are released from state prison and reincarceration is measured as the first instance of returning to state prison after an offender is released from state prison. Overall recidivism is measured as the first instance of any type of rearrest or reincarceration after inmates are released from state prison.
Time frame: at year 3
Number of Productive Activities Hours
Productive Activities Hours include competitive employment (hours worked), and volunteer work (hours worked), brain injury clubhouses (hours attended), vocational training program (hours attended), and education (hours attended).
Time frame: up to 36 months post release
Number or Participants Engaged in Productive Activity
The number of participants who engage in vocational training program or education activity at end of program.
Time frame: up to 36 months post release
Number of Participants Engaged with Services
Engagement with Services. Engagement with Services includes community-based specialized NeuroRehabilitation services (physical therapy, occupational therapy, speech therapy, cognitive rehabilitation therapy, neuropsychology), and vocational rehabilitation services (job development, job placement, job coaching).
Time frame: up to 36 months post release
Number of Participants Connected to Health/Medical Resources
The connection to Health/Medical resources will also be measured, "safety net" resources (SNAP, MA, SSI, food bank, etc).
Time frame: up to 36 months post release
Number of participants in Community Support
Community Support - Participation in support groups and recovery resources, including religious activities, recreation, and access to transportation.
Time frame: up to 36 months post release
Number of Participants in Stable Housing
Community Support - whether the ex-offender has stable housing
Time frame: up to 36 months post release
Number of Parole Obligations Met
Parole Obligations - the extent to which the ex- offender has satisfied the obligations of Parole will be tracked, such as whether they have completed all mandated treatment
Time frame: up to 36 months post release
Number of Participants Discharged from Supervision
Number of participants that have been or (are likely to be) discharged from supervision.
Time frame: up to 36 months post release
Date of Reception
The day on which an individual was initially received into the custody
Time frame: up to 36 months post release
Date Committed
The day on which an individual was committed to sentenced
Time frame: up to 36 months post release
Date of entry into Department of Corrections
The day on which an individual was admitted into the Department of Corrections
Time frame: up to 36 months post release
Number of Participants with particular Classification of Offense
Number of Participants with particular Classification of Offense as listed by the Department of Corrections
Time frame: up to 36 months post release
Number of participants who are Guilty but mentally ill
Number of participants who are guilty but mentally ill
Time frame: up to 36 months post release
Number of Participants Recommended for aftercare
Number of Participants Recommended to receive aftercare
Time frame: up to 36 months post release
Status of Participants after Program completion
Status of Participants after Program completions as determined by the Department of Corrections
Time frame: up to 36 months post release
Program category
Program category as as determined by the Department of Corrections
Time frame: up to 36 months post release
Plan to share: Yes — All of the individual participant data collected during the trial, after deidentification.
Supporting information: Study protocol, Statistical analysis plan, Informed consent form
Time frame: Immediately following publication. No end date.
Access criteria: Researchers who provide a methodologically sound proposal. To achieve aims in the approved proposal. Proposals should be directed to maria.kajankova@mountsinai.org. To gain access, data requestors will need to sign a data access agreement. Data are available for 5 years at a third party website (Link tbd).
No publications or documents are linked to this record.
Started Mar 2022 (actual). Primary completion is estimated for Dec 2026, 57 months after the start.
Of 285 non-industry interventional studies with no phase under Brain Injuries, half reached primary completion within 26 months of starting (the median), counting those still running; a quarter within 14 and three quarters within 50. This study's planned 57 months is above that.
Counting every sponsor, half of 298 studies reached it within 24 months; a quarter within 12 and three quarters within 48.
How these figures are worked out, and which studies are left out of them.
This study is active, not recruiting, as verified in Jan 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Icahn School of Medicine at Mount Sinai →